Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphocyte Function-Associated Antigen-1 | 6 | 2000 | 73 | 0.550 |
Why?
|
| Paraneoplastic Syndromes | 2 | 2011 | 82 | 0.470 |
Why?
|
| Neutrophils | 7 | 2000 | 873 | 0.440 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 257 | 0.400 |
Why?
|
| Synovitis | 1 | 2011 | 23 | 0.390 |
Why?
|
| Arthritis, Infectious | 1 | 2012 | 75 | 0.390 |
Why?
|
| Anemia | 2 | 2015 | 728 | 0.380 |
Why?
|
| Candida | 1 | 2012 | 171 | 0.370 |
Why?
|
| Arthritis | 1 | 2011 | 148 | 0.360 |
Why?
|
| Candidiasis | 1 | 2012 | 278 | 0.340 |
Why?
|
| Hydrogen Peroxide | 2 | 2000 | 223 | 0.330 |
Why?
|
| Primary Myelofibrosis | 2 | 2015 | 914 | 0.320 |
Why?
|
| Macrophage-1 Antigen | 6 | 2000 | 55 | 0.290 |
Why?
|
| Intercellular Adhesion Molecule-1 | 4 | 2000 | 227 | 0.280 |
Why?
|
| Cell Adhesion | 8 | 2000 | 1028 | 0.250 |
Why?
|
| CD18 Antigens | 6 | 2003 | 86 | 0.220 |
Why?
|
| Respiratory Burst | 2 | 2000 | 22 | 0.190 |
Why?
|
| Diagnosis, Differential | 4 | 2015 | 4831 | 0.180 |
Why?
|
| Autoimmune Diseases | 2 | 2015 | 436 | 0.160 |
Why?
|
| Cell Movement | 3 | 1999 | 2472 | 0.130 |
Why?
|
| Hematologic Tests | 1 | 2015 | 84 | 0.120 |
Why?
|
| Myocardium | 1 | 2000 | 1232 | 0.120 |
Why?
|
| Triazoles | 2 | 2013 | 627 | 0.110 |
Why?
|
| Synovial Fluid | 1 | 2012 | 27 | 0.100 |
Why?
|
| Chondrocalcinosis | 1 | 2012 | 26 | 0.100 |
Why?
|
| Arthralgia | 1 | 2013 | 97 | 0.100 |
Why?
|
| Drug Resistance, Fungal | 1 | 2012 | 98 | 0.100 |
Why?
|
| Knee Joint | 1 | 2012 | 166 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2007 | 1067 | 0.090 |
Why?
|
| Dogs | 4 | 2000 | 1160 | 0.090 |
Why?
|
| Rheumatic Diseases | 1 | 2011 | 100 | 0.090 |
Why?
|
| Bone Diseases | 1 | 2011 | 143 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2000 | 2928 | 0.090 |
Why?
|
| Growth Plate | 1 | 2010 | 43 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2012 | 822 | 0.090 |
Why?
|
| Leukocyte-Adhesion Deficiency Syndrome | 2 | 2000 | 6 | 0.090 |
Why?
|
| Chondrocytes | 1 | 2010 | 100 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2010 | 81 | 0.090 |
Why?
|
| Bone Resorption | 1 | 2010 | 137 | 0.080 |
Why?
|
| Neoplasms | 3 | 2011 | 15927 | 0.080 |
Why?
|
| Chemotactic Factors | 2 | 2000 | 42 | 0.080 |
Why?
|
| E-Selectin | 3 | 2010 | 106 | 0.080 |
Why?
|
| Nitriles | 1 | 2013 | 939 | 0.080 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2013 | 841 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2015 | 2441 | 0.070 |
Why?
|
| Immunocompromised Host | 1 | 2011 | 719 | 0.070 |
Why?
|
| Antifungal Agents | 1 | 2012 | 880 | 0.070 |
Why?
|
| bcl-X Protein | 1 | 2005 | 198 | 0.060 |
Why?
|
| Kinetics | 2 | 2000 | 2220 | 0.060 |
Why?
|
| Osteoporosis | 1 | 2007 | 232 | 0.060 |
Why?
|
| Homeostasis | 1 | 2010 | 925 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 1109 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2007 | 310 | 0.060 |
Why?
|
| Viral Envelope Proteins | 1 | 2005 | 219 | 0.060 |
Why?
|
| Chemotaxis | 1 | 2003 | 136 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2003 | 219 | 0.050 |
Why?
|
| Male | 10 | 2015 | 128315 | 0.050 |
Why?
|
| Bone Neoplasms | 2 | 2011 | 2665 | 0.050 |
Why?
|
| Humans | 15 | 2015 | 270740 | 0.050 |
Why?
|
| T-Lymphocytes | 3 | 2005 | 3949 | 0.050 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2000 | 15 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 593 | 0.040 |
Why?
|
| Antineoplastic Agents | 3 | 2011 | 14617 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 340 | 0.040 |
Why?
|
| Helminth Proteins | 1 | 2000 | 111 | 0.040 |
Why?
|
| Azepines | 1 | 2000 | 134 | 0.040 |
Why?
|
| Animals | 13 | 2010 | 61956 | 0.040 |
Why?
|
| Endothelium, Vascular | 2 | 2000 | 879 | 0.040 |
Why?
|
| Skin Ulcer | 1 | 1998 | 74 | 0.040 |
Why?
|
| Mice, Knockout | 6 | 2010 | 5728 | 0.040 |
Why?
|
| Mice | 9 | 2010 | 35600 | 0.040 |
Why?
|
| Thioglycolates | 1 | 1997 | 8 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2000 | 327 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 1997 | 47 | 0.040 |
Why?
|
| Neutrophil Activation | 1 | 1997 | 35 | 0.040 |
Why?
|
| L-Selectin | 1 | 1997 | 36 | 0.040 |
Why?
|
| Peritonitis | 1 | 1997 | 99 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2000 | 779 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 1997 | 655 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2000 | 1474 | 0.030 |
Why?
|
| Transfection | 1 | 2000 | 3117 | 0.030 |
Why?
|
| Prolactin | 1 | 1995 | 169 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 1642 | 0.030 |
Why?
|
| Inflammation | 2 | 2003 | 2518 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 2000 | 160 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2000 | 5694 | 0.030 |
Why?
|
| Inhibins | 1 | 1994 | 116 | 0.030 |
Why?
|
| Female | 10 | 2013 | 148940 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2003 | 7100 | 0.030 |
Why?
|
| Aged | 4 | 2013 | 73333 | 0.030 |
Why?
|
| Cachexia | 1 | 1994 | 165 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2013 | 9470 | 0.030 |
Why?
|
| Adult | 3 | 2015 | 82040 | 0.020 |
Why?
|
| Apoptosis | 1 | 2005 | 7757 | 0.020 |
Why?
|
| Fractures, Spontaneous | 1 | 2011 | 87 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 1995 | 1179 | 0.020 |
Why?
|
| Selectins | 1 | 2010 | 5 | 0.020 |
Why?
|
| Furin | 1 | 2010 | 11 | 0.020 |
Why?
|
| Stem Cells | 1 | 1997 | 1216 | 0.020 |
Why?
|
| Sialoglycoproteins | 1 | 2010 | 151 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2000 | 4481 | 0.020 |
Why?
|
| Lung | 2 | 2003 | 3298 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1996 | 1654 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1995 | 1138 | 0.020 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2010 | 153 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2010 | 271 | 0.020 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1994 | 527 | 0.020 |
Why?
|
| Cell Line | 1 | 1997 | 5338 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1995 | 1624 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2013 | 1016 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 16215 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2011 | 605 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2010 | 702 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2005 | 6685 | 0.020 |
Why?
|
| Ligands | 1 | 2010 | 1012 | 0.020 |
Why?
|
| Bone Density | 1 | 2010 | 466 | 0.020 |
Why?
|
| Geography | 1 | 2007 | 140 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 1184 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1995 | 3339 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2007 | 9039 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2005 | 319 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 4567 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2005 | 197 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 16689 | 0.020 |
Why?
|
| Growth Substances | 1 | 2005 | 326 | 0.020 |
Why?
|
| Interleukin-8 | 2 | 1997 | 531 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 2003 | 17 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1995 | 4130 | 0.010 |
Why?
|
| Leishmania major | 1 | 2003 | 27 | 0.010 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2003 | 54 | 0.010 |
Why?
|
| SEER Program | 1 | 2007 | 1047 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2003 | 290 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 5824 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 1472 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 4223 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1995 | 5002 | 0.010 |
Why?
|
| Risk Factors | 2 | 2010 | 17888 | 0.010 |
Why?
|
| Medicare | 1 | 2007 | 926 | 0.010 |
Why?
|
| Failure to Thrive | 1 | 2000 | 96 | 0.010 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1999 | 9 | 0.010 |
Why?
|
| Interphase | 1 | 1999 | 156 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1999 | 342 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 4116 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2000 | 735 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2000 | 425 | 0.010 |
Why?
|
| Organ Size | 1 | 2000 | 692 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1999 | 268 | 0.010 |
Why?
|
| Registries | 1 | 2007 | 2211 | 0.010 |
Why?
|
| Zymosan | 1 | 1998 | 11 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 2454 | 0.010 |
Why?
|
| Leukocytes | 1 | 2000 | 421 | 0.010 |
Why?
|
| Base Sequence | 2 | 1995 | 5437 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1998 | 197 | 0.010 |
Why?
|
| Enterotoxins | 1 | 1998 | 122 | 0.010 |
Why?
|
| Phenotype | 2 | 2000 | 6509 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2003 | 7381 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2000 | 770 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2007 | 30998 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2000 | 968 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2010 | 12103 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2000 | 949 | 0.010 |
Why?
|
| Platelet Activating Factor | 1 | 1996 | 57 | 0.010 |
Why?
|
| Body Weight | 1 | 2000 | 1307 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 1998 | 404 | 0.010 |
Why?
|
| Skin | 1 | 2000 | 1271 | 0.010 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 1995 | 54 | 0.010 |
Why?
|
| Rhinovirus | 1 | 1995 | 67 | 0.010 |
Why?
|
| Neoplasms, Gonadal Tissue | 1 | 1994 | 3 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1997 | 541 | 0.010 |
Why?
|
| Picornaviridae Infections | 1 | 1995 | 55 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2000 | 1757 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1999 | 1723 | 0.010 |
Why?
|
| Malaria | 1 | 1995 | 92 | 0.010 |
Why?
|
| Activins | 1 | 1994 | 94 | 0.010 |
Why?
|
| S Phase | 1 | 1995 | 288 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1995 | 257 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 1995 | 162 | 0.010 |
Why?
|
| G1 Phase | 1 | 1995 | 305 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1999 | 1584 | 0.010 |
Why?
|
| Orchiectomy | 1 | 1994 | 211 | 0.010 |
Why?
|
| Cell Division | 1 | 1998 | 2657 | 0.010 |
Why?
|
| Gene Library | 1 | 1995 | 353 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1995 | 337 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 12541 | 0.010 |
Why?
|
| Species Specificity | 1 | 1995 | 794 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1995 | 498 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1995 | 938 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 1082 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1997 | 1356 | 0.010 |
Why?
|
| Ovariectomy | 1 | 1994 | 371 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1998 | 1137 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 14012 | 0.010 |
Why?
|
| Binding Sites | 1 | 1995 | 2255 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 3028 | 0.010 |
Why?
|
| United States | 1 | 2007 | 15861 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 22505 | 0.010 |
Why?
|
| Protein Binding | 1 | 1995 | 3485 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 2573 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1996 | 6390 | 0.000 |
Why?
|
| Rats | 1 | 1995 | 6441 | 0.000 |
Why?
|
| Middle Aged | 1 | 2013 | 90352 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2007 | 39890 | 0.000 |
Why?
|